Introduction
Neo-adjuvant (chemo)radiotherapy plays an important role in the multidisciplinary treatment of rectal cancer [
1], primarily aiming to reduce local recurrence rates [
2,
3] and to downstage the tumor prior to surgery. Accurate radiotherapy delivery to the tumor and elective lymph nodes is hampered by geometrical uncertainties arising from delineation uncertainty, and inter- and intrafraction anatomical variations. To accommodate these uncertainties, the clinical target volume (CTV) is expanded to a planning target volume (PTV). This target volume typically overlaps with the organs at risk (OAR) such as the bladder and the small bowel, resulting in high OAR dose and consequent toxicity [
4,
5]. Studying mesorectum motion is important for optimizing rectal cancer radiotherapy in which the mesorectum receives a homogeneous dose in either short or long treatment schedules. Within the context of organ preservation for intermediate and high risk rectal cancer patients, safe dose escalation to the primary tumor may be enabled with the use of smaller PTV margins around the GTV [
6].
Recently, integrated MRI linear accelerators were introduced, allowing the use of MRI for online image guidance. With MRI-guided radiotherapy (MRIgRT) high soft tissue contrast images can be acquired at several time points during the treatment which enables daily online adaptation to anatomical changes between treatment fractions and monitoring of anatomical changes during treatment [
7]. By planning using delineations of the anatomy on images acquired just prior to the treatment, MRIgRT allows for reduction of geometrical uncertainties due to interfraction motion. As a result of daily online adaptation, intrafraction motion and delineation uncertainty are the primary remaining uncertainties [
8]. Online adaptation for rectal cancer is time-consuming with a median duration of 36 min [
9] as it requires online redelineation and plan optimization based on the image of the day. As demonstrated by Kleijnen et al. [
10], intrafraction motion increases with time requiring larger PTV margins for longer treatment durations. Ideally, to reduce intrafraction motion, online adaptation could be accelerated by automated methods, like auto-contouring or auto-planning, however these methods are still in development for routine clinical use [
11].
Strategies for intrafraction motion monitoring and subsequent motion management, including beam gating and multi-leaf collimator tracking, allow for the reduction of uncertainties arising from intrafraction motion. With gating, the target position is monitored continuously and radiation is only delivered if the target is within a pre-defined envelope. Gating has been widely implemented, but its application is mostly limited to periodic motion [
12,
13]. Although rectal motion is non-periodic, gating has been applied for mitigating rectal intrafraction motion [
14]. Next to gating, tracking has been investigated [
15,
16], although it is not clinically available to date on MRI linear accelerators. An alternative, simpler, intrafraction adaptation strategy is to acquire a verification MRI to evaluate target motion during redelineation and plan adaptation, and perform a 2nd adaptation if the target has moved outside a pre-defined envelope. This adaptation can be done by repeating the workflow for the initial adaptation. Adapting based on the verification MRI will probably provide a better surrogate for the anatomy on the post treatment MRI than the adaptation MRI considering the shorter time interval between the scans. As a result of the shorter time interval, target motion may possibly be smaller and a further reduction of PTV margins may be possible. Margin reduction has been studied for prostate [
17,
18], lung [
19], cervical [
20,
21] and spine irradiation [
22], however no studies focusing on the potential benefit of intrafraction motion management on PTV margins for rectal cancer were found.
The aim of this work was therefore to determine the PTV margins required to accommodate intrafraction motion of the mesorectum during standard MRIgRT and of the primary tumor during dose-escalated MRIgRT of rectal cancer and secondly to determine the potential benefit of performing a 2nd adaptation prior to irradiation.
Discussion
The aim of this study was to determine the PTV margins required to accommodate intrafraction motion of the mesorectum (CTVmeso) and the gross tumor volume (GTVprim) during MRIgRT of rectal cancer and to determine if performing a 2nd adaptation prior to irradiation would potentially be beneficial.
For the CTVmeso we found a required margin of 6.4 mm in the anterior direction and 4.0 mm in all other directions without a 2nd adaptation. Introducing 2nd adaptations allowed a reduction to 3.2 mm in the anterior direction and 2.0 mm in all other directions. For the GTVprim, a PTV margin of 5.0 mm was needed, whereas 2nd adaptations allowed for a reduction to 3.5 mm.
Several studies have reported on the motion of the CTV
meso [
10,
29‐
32] and GTV
prim [
10,
33,
34].
Kleijnen et al. studied the motion uncertainty as a function of time of CTV
meso and GTV
prim using repeated cine-MRI data of 16 patients [
10]. They found PTV margins of 12 mm for intrafraction motion up to 18 min which were comparable in magnitude to margins found for interfraction motion [
10]. The differences are likely due to the use of different coverage criteria. In the study of Kleijnen et al., the distance that incorporates 95% of the surface voxels at the investigated time point was required to fit within the margin in 90% of all fractions. In our work the margin was selected for an average volumetric coverage of 95% in 90% of all patients.
With regards to PTV
prim, our findings are in line with previous studies [
33,
34]. Van de Ende et al. studied the inter- and intrafraction displacement of the GTV based on fiducial markers on cone beam CT images and reported PTV margins of 3.0 mm in left–right direction, 4.7 mm in anterior–posterior direction and 5.5 mm in cranial-caudal direction for intrafraction displacement [
33]. In addition, they showed larger motion for proximal tumors as compared to distal tumors and hypothesized that the reduction of required margins may be higher in patients with a proximal compared to a distal tumor.
More recently, Eijkelenkamp et al. determined margins to compensate for intrafraction GTV
prim motion during online adaptive procedures [
34]. They used a similar method as the current study to determine the required margin for online adaptive MR-guided dose escalation for intermediate risk rectal cancer patients and reported a margin of 6 mm for the entire treatment, which could be reduced to 4 mm for a procedure of 15 min or less. These findings are consistent with the PTV margins found in current study.
Although intrafraction motion for CTV
meso and GTV
prim has been studied previously, the current study also explores the potential benefit of intrafraction motion management during MRI-guided radiotherapy to reduce the required PTV margins. As shown in the results, adapting just prior to the start of irradiation instead of only at the beginning of the treatment possibly provides a more accurate estimation of the anatomy during irradiation in some cases, given the shorter time interval between MRI
ver and MRI
post compared to MRI
adapt and MRI
post. For GTV
prim relatively more 2nd adaptations were needed to achieve a margin reduction of 30%. This may possibly be attributed to the larger observer variability for the primary tumor as compared to mesorectum [
35]. In addition, when considering the number of 2nd adaptations and the resulting margins for different verification envelopes as depicted in Fig.
3, one can make a tradeoff between the workload and the benefit of motion management to reduce the required margins.
When assessing the effect of the margin reduction on bowel toxicity, we showed that the volume of the bowel receiving 95% of the prescribed dose (23 Gy) is reduced with only 16.0 cm
3 after performing 2nd adaptations. Both before and after 2nd adaptations, the volume of bowel area receiving 23 Gy was lower than the upper limit of 85 cm
3 recommended by adapted Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) guidelines [
36]. Considering this, the clinical impact of margin reduction as a result of 2nd adaptations might be limited for dose reduction to the bowel. Overall the choice to treat a patient on a MR-Linac systems is carefully considered by clinicians weighing the clinical benefits against the added time and workload. With daily online adaptation and motion management where needed the treatment is tailored to each patients’ anatomy, allowing for more accurate RT, reduced margins and possibly dose escalation.
In this study we introduced a verification envelope (VE) for deciding when to perform a 2nd adaptation. The coverage threshold based on this VE replaces the common practice to take action if the target moves out of the PTV. As demonstrated in the results, the required PTV margin is typically not identical to the VE. Using the PTV margin as envelope can result in performing either too few or too many 2nd adaptations than necessary. The concept of a VE is consistent with motion management techniques such as automated beam gating [
37] and target tracking [
38] as these are solely based on movement of the target outside of a pre-specified threshold, and do not inherently use the PTV margin for this purpose. Up to date there is one study by Chiloiro et al. [
14] demonstrating the clinical feasibility of beam gating in rectal cancer with a region of interest set around the mesorectum.
A limitation of this study was that the duration of the 2nd adaptations was not considered. We assumed an instantaneous adaptation, which is not feasible in clinical practice. When performing the 2nd adaptation, motion may occur during that time period as well. Consequently, the margins found in this study should be considered a lower boundary of what would be achievable. Our method for 2nd adaptations uses new delineations on MRI
ver, which would be consistent with an Adapt to Shape workflow on the Unity system. Although full redelineation as part of a 2nd adaptation is the most accurate approach to account for intrafractional anatomical changes, this method tends to be time-intensive, but is expected to be faster than the first adaptation. Because we assume the 2nd adaptation to be faster, we used the volume differences between the contours prior to and after adaptation as an estimate for the adaptation time. Here volume differences were used as a surrogate for the added path length [
39] and we saw that volume differences were significantly smaller for the 2nd adaptation.
At the time of adapting for the 2nd time, the patient has been on the treatment table for a while and may be more relaxed, possibly resulting in a reduced amount of motion as compared to the first adaptation. An option to limit the adaptation time might be to opt for a less accurate and faster approach such as Adapt to Position [
23]. However, a downside is that the Adapt to Position approach only corrects rigid translations of the target volume. Nevertheless, the exact implications of the duration of 2nd adaptation remain to be studied further. Speeding up the first adaptation, specifically delineation, might be the ideal solution. However, automation methods such as auto contouring are still in development.
The criteria for margin determination were based on volumetric coverage and not statistical inferences from accumulated dose as is done in deriving the classical margin recipes [
40,
41]. For a comparison with these recipes the local standard deviation of the positioning error should have been determined. However, to translate this into a margin, assumptions on the dose distribution, local distribution of positioning errors and target deformation have to be made. Our volumetric approach is considerably easier to interpret and requires only the choice of a coverage criterion. However to formally asses that, a dose accumulation study needs to be performed. Because of the heuristic nature of these choices we also provided results for different coverage criteria.
The proposed margins primarily account for uncertainties due to intrafraction motion conform the online adaptive workflow. In the total PTV used in clinical practice other uncertainties such as uncertainties in gantry positioning, MLC motion, image alignment should be included. Gantry position and choices related to MLC positioning are typically institute-specific. When using this work to determine margins for clinical practice, care should be taken to ensure that all relevant uncertainties are taken into account.
Given the comparison of two delineations on different scans, the analysis is potentially influenced by delineation variability. However, within a single patient we minimized this variation by having the same observer delineate all scans of one patient. Moreover, for the verification and post treatment scan the delineation was performed by adjusting a copy of the delineation on the adaptation scan, minimizing the delineation variability within a single fraction.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.